News | September 27, 2024
Torrent Pharmaceuticals refutes claims of Shelcal 500 allegedly failing CDSCO quality test
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
The company has entered into a long-term lease and operations and management agreement with Sree Chand Specialty Hospital, situated in Kannur
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
The initiation of a second Phase 3 clinical trial for bomedemstat demonstrates company’s commitment to advancing research in myeloproliferative neoplasms (MPNs)
The new Injectable Facility housed in Akums Healthcare started commercial production on 22nd August 2024, with a capacity of 362 million units annually
e brings over 27+ years of rich pharmaceutical experience
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
Both departments will be equipped with specialized professionals and state-of-the-art facilities ensuring the highest standards of care
SMS Pharmaceuticals has reported total income of Rs. 165.81 crores during the quarter ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated
